SEATTLE and VANCOUVER, British Columbia - Achieve Life Sciences, Inc. (NASDAQ: NASDAQ:ACHV), a specialty pharmaceutical company currently trading near its 52-week low at $3.05, has announced the Data ...

Kristen Altus is an associate editor with Fox News Digital. Kristen joined Fox News in 2021 as a production assistant and previously worked as a news writer for Miami’s WSVN-TV.With FOX Business ...

Achieve Life Sciences (ACHV) announced that the Data Safety Monitoring Committee, DSMC, has recently completed its second independent review of the ongoing ORCA-OL trial, evaluating long-term ...

Lake Street analyst Thomas Flaten reiterated a Buy rating on Achieve Life Sciences (ACHV – Research Report) today and set a price target of $11.00. The company’s shares closed last Friday at $ ...

Slaoui is noted for his work with Operation Warp Speed, the COVID-19 vaccine project launched by the Trump administration, where he was scientific head until he stepped down in January.

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises "substantial doubt" about its ability to continue as a going concern.

I cover Philly schools, taking readers inside one of the largest districts in the country. I love a good drum line and a great classroom tale.